Profil
Holger Neecke is Chief Executive Officer at Tethis SpA since 2022.
Former roles include Director-Investor Relations at AGC Biologics SpA from 2001 to 2010 and Senior Director-Business Development at Ablynx NV.
Education includes an undergraduate degree from the University of Basel, an MBA from the University of Bocconi, and a doctorate from the University of Milan.
Postes actifs de Holger Neecke
| Sociétés | Poste | Début |
|---|---|---|
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Develops liquid biopsy platforms and AI-assisted diagnostic solutions for cancer detection and precision medicine | Directeur Général | 20/10/2022 |
Anciens postes connus de Holger Neecke
| Sociétés | Poste | Fin |
|---|---|---|
| ABLYNX | Corporate Officer/Principal | - |
| MOLMED S.P.A. | Investor Relations Contact | - |
Formation de Holger Neecke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
AGC Biologics SpA
AGC Biologics SpA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services for protein-based biologics, cells & gene therapies and messenger RNA | Health Technology |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bocconi
University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Milan
University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Develops liquid biopsy platforms and AI-assisted diagnostic solutions for cancer detection and precision medicine | Health Technology |
















